AS Brains Bioceuticals unveiled a significant expansion of its UK production facilities, it has warned that any future investment is
As the European Commission begins to release updates on CBD products that have made it through to the final stage of the Novel Food process, Dean Billington of Brains Bioceutical reflects on the impact of this lengthy process.
WITH the Democrats in control of the White House, Senate and Congress Wall Street now beckons for America’s cannabis industry.
THE comings and goings over the status of CBD as a food or a drug is no longer academic as
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
